DuPont (Dymel Pharma Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

DuPont (Dymel Pharma Business) General Information

Description

Developer of pharmaceuticals. The company offers medicines used in the treatment of HIV, cardiovascular disease, central nervous system disorders, cancer and inflammatory diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
SRF Limited
Primary Office
  • 1007 Market Street
  • Wilmington, DE 19898
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DuPont (Dymel Pharma Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DuPont (Dymel Pharma Business)‘s full profile, request access.

Request a free trial